tiprankstipranks
Advertisement
Advertisement
Danaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated
PremiumRatingsDanaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated
26d ago
Danaher’s recent volatility presents buying opportunity, says Argus
Premium
The Fly
Danaher’s recent volatility presents buying opportunity, says Argus
30d ago
Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance
Premium
Ratings
Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance
1M ago
Danaher price target lowered to $220 from $260 at Stifel
PremiumThe FlyDanaher price target lowered to $220 from $260 at Stifel
1M ago
Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength
Premium
Ratings
Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength
1M ago
Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230
Premium
Ratings
Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230
1M ago
Danaher Stock (DHR) Is Down 13% and Suffering Its Worst Decline in 30 Years. Here’s Why
PremiumMarket NewsDanaher Stock (DHR) Is Down 13% and Suffering Its Worst Decline in 30 Years. Here’s Why
1M ago
Danaher falls -14.3%
Premium
The Fly
Danaher falls -14.3%
1M ago
Midday Fly By: GM, 3M, Hasbro all post beat and raise reports
Premium
The Fly
Midday Fly By: GM, 3M, Hasbro all post beat and raise reports
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100